E-LIB Suche - Ergebnisse für: Goh, Yeow Tee

1

Asciminib monotherapy in patients with CML-CP without BCR::..:

Mauro, Michael J ; Hughes, Timothy P ; Kim, Dong-Wook...
https://research.vumc.nl/en/publications/6d526334-4128-4e79-a87b-30d3fb304c73. , 2023

Link: https://research.vumc.nl..

2

Asciminib monotherapy in patients with CML-CP without BCR::..:

Mauro, Michael J ; Hughes, Timothy P ; Kim, Dong-Wook...
https://research.vumc.nl/en/publications/6d526334-4128-4e79-a87b-30d3fb304c73. , 2023

Link: https://research.vumc.nl..

3

Narsoplimab, a Mannan-Binding Lectin-Associated Serine Prot..:

Khaled, Samer K ; Claes, Kathleen ; Goh, Yeow Tee...
info:eu-repo/semantics/altIdentifier/pmid/35439028. , 2022

Link: http://hdl.handle.net/24..

4

MPN-478 MOMENTUM: Phase 3 Randomized Study of Momelotinib (..:

Mesa, Ruben ; Gerds, Aaron ; Vannucchi, Alessandro...
Clinical Lymphoma Myeloma & Leukemia, Vol.22, pp.S339-S340. , 2022

Link: https://hdl.handle.net/1..

5

MPN-483 Thrombocytopenic Myelofibrosis (MF) Patients Previo..:

Gerds, Aaron ; Verstovsek, Srdan ; Vannucchi, Alessandro...
Clinical Lymphoma, Myeloma and Leukemia, Vol.22, p. S340. , 2022

Link: https://hdl.handle.net/1..

6

Improved Transfusion Independence Rates for Momelotinib ver..:

Kiladjian, Jean-Jacques ; Platzbecker, Uwe ; Mayer, Jiri...
British Journal of Haematology, Vol.197, pp.81-81. , 2022

Link: https://hdl.handle.net/1..

7

DDX3X loss is an adverse prognostic marker in diffuse large..:

Kizhakeyil, Atish ; Zaini, Nurmahirah Binte Mohammed ; Poh, Zhi Sheng...
https://www.repository.cam.ac.uk/handle/1810/329796. , 2021

Link: https://www.repository.c..

8

DDX3X loss is an adverse prognostic marker in diffuse large..:

Kizhakeyil, Atish ; Zaini, Nurmahirah Binte Mohammed ; Poh, Zhi Sheng...
doi:10.17863/CAM.78291. , 2021

Link: https://doi.org/10.17863..

9

Phase 1 study of inotuzumab ozogamicin combined with R-GDP ..:

Sangha, Randeep ; Davies, Andrew ; Dang, Nam H...
https://eprints.soton.ac.uk/417872/1/Phase_1_study_of_inotuzumab_ozogamicin_combined_with_R_GDP_for_the_treatment_of_patients_with_relapsed_refractory_CD22_B_cell_non_Hodgkin_lymphoma.pdf. , 2017

Link: https://eprints.soton.ac..

10

Treatment outcomes of T and natural‐killer/T‐cell lymphoma ..:

Tricia Tay ; Nagavalli Somasundaram ; Cindy Lim...
https://doi.org/10.1002/cnr2.1552. , 2022

Link: https://doi.org/10.1002/..

11

High-dose methotrexate is effective for prevention of isola..:

Shin Yeu Ong ; Sanjay de Mel ; Nicholas Francis Grigoropoulos...
https://doi.org/10.1038/s41408-021-00535-y. , 2021

Link: https://doi.org/10.1038/..

12

DDX3X loss is an adverse prognostic marker in diffuse large..:

Atish Kizhakeyil ; Nurmahirah Binte Mohammed Zaini ; Zhi Sheng Poh...
https://doi.org/10.1186/s12943-021-01437-0. , 2021

Link: https://doi.org/10.1186/..

13

A phase 2 study of carfilzomib, cyclophosphamide and dexame..:

Yunxin Chen ; Sathish Kumar Gopalakrishnan ; Melissa Ooi...
https://doi.org/10.1038/s41408-021-00544-x. , 2021

Link: https://doi.org/10.1038/..

14

Use of Valacyclovir for the treatment of cytomegalovirus an..:

Ong, Shin-Yeu ; Truong, Ha-Thi-Thu ; Diong, Colin...
http://www.biomedcentral.com/2052-1839/15/8. , 2015

Link: http://www.biomedcentral..

15

Studies of Wilms' Tumor (WT1) Gene Expression in Adult Acut..:

Che Kang Lim ; Yeow Tee Goh ; William Y. K. Hwang..
http://la-press.com/article.php?article_id=326. , 2007

Link: https://doaj.org/article..